Neuromuscular Blockade Reversal
Pregnancy: B — limited data
Sugammadex
Brand names: Bridion
Adult dose
Dose: 2–16mg/kg IV depending on depth of block
Route: IV bolus
Frequency: Single dose
Routine reversal (T2 reappearance): 2mg/kg. Deep block (1–2 post-tetanic counts): 4mg/kg. Immediate reversal after rocuronium: 16mg/kg. Give as rapid IV bolus.
Paediatric dose
Dose: 2 mg/kg
Route: IV
Frequency: Single dose
Children 2–17 years: same weight-based dosing as adults (2 or 4 mg/kg). Not licensed for infants <2 years.
Paediatric weight-based calculator
Children 2–17 years: same weight-based dosing as adults (2 or 4 mg/kg). Not licensed for infants <2 years.
Clinical pearls
- Encapsulates rocuronium and vecuronium — does NOT work for other muscle relaxants (suxamethonium, atracurium)
- Much faster and more reliable than neostigmine — preferred for routine and emergency reversal
- Hormonal contraceptive warning: advise additional contraception for 7 days post-dose (equivalent to missing one oral pill)
- Cannot be re-used within 24h — complex persists for extended period
- Bradycardia reported — have atropine available
Contraindications
- Hypersensitivity to sugammadex
Side effects
- Bradycardia
- Hypersensitivity/anaphylaxis (rare but can be severe)
- Recurrence of neuromuscular block (rare)
Interactions
- Toremifene, fusidic acid — may displace rocuronium from sugammadex (reduced reversal efficacy)
- Hormonal contraceptives — sugammadex may reduce efficacy of OCP (use additional contraception for 7 days)
Monitoring
- Neuromuscular function (TOF ratio — confirm T4/T1 ≥0.9 before extubation)
- SpO2 post-reversal
- HR
Reference: BNFc; AAGBI/RCoA Neuromuscular Block Guidelines; BNF. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Train-of-Four (TOF) Neuromuscular Monitoring · Neuromuscular Blockade
- Fresh Frozen Plasma (FFP) Dose Calculator · Transfusion Medicine
- New Ballard Score — Gestational Age Assessment · Gestational Age
- MGFA Clinical Classification for Myasthenia Gravis · Neuromuscular
- Myasthenia Gravis Activities of Daily Living (MG-ADL) Scale · Neuromuscular
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH